Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study

Practice Patterns in the Management of Chronic Obstructive Pulmonary Disease in Primary Practice: The Cage Study

(2016) Jean Bourbeau et al.   Canadian Respiratory Journal

Controversies in treatment of chronic obstructive pulmonary disease

(2011) Klaus F Rabe et al.   LANCET

Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health Status

(2011) Javier de Miguel-Díez et al.   LUNG

Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies

(2011) Y. K. Loke et al.   THORAX

The UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK

(2009) Mark Strong et al.   BMC HEALTH SERVICES RESEARCH

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

(2009) Stephen I. Rennard et al.   DRUGS

Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

(2008) Donald P Tashkin et al.   DRUGS

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

(2007) Jadwiga A. Wedzicha et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE